Treatment of paroxysmal dyskinesias

Bibliography

• Guerrini R. Epilepsy and movement disorders. Cambridge University Press, Cambridge, New York; 2002. xxvii, 557 p
   Google Scholar
• Kaplan PW, Fisher RS. Imitators of epilepsy. 2nd edition. Demos, New York, NY; 2005. xv, 296 p
   Google Scholar
• Crompton DE, Berkovic SF. The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol 2009;8(4):370-81
   PubMedGoogle Scholar
• Jen JC, Graves TD, Hess EJ, Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007;130(Pt 10):2484-93
   PubMedGoogle Scholar
• Weber YG, Lerche H. Genetics of paroxysmal dyskinesias. Curr Neurol Neurosci Rep 2009;9(3):206-11
   PubMedGoogle Scholar
• Goodenough DJ, Fariello RG, Annis BL, Familial and acquired paroxysmal dyskinesias. A proposed classification with delineation of clinical features. Arch Neurol 1978;35(12):827-31
   PubMedGoogle Scholar
• Lance JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 1977;2(4):285-93
   PubMedGoogle Scholar
• Mount LA, Reback S. Familial paroxysmal choreoathetosis. Arch Neurol Psychiatry 1940;44:841-7
   Google Scholar
• Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 1967;17(7):680-90
   PubMedGoogle Scholar
• Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38(4):571-9
   PubMedGoogle Scholar
• Jankovic J, Demirkiran M. Classification of paroxysmal dyskinesias and ataxias. Adv Neurol 2002;89:387-400
   PubMedGoogle Scholar
• Lugaresi E, Cirignotta F. Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? Sleep 1981;4(2):129-38
   PubMedGoogle Scholar
• Lugaresi E, Cirignotta F Montagna P. Nocturnal paroxysmal dystonia. J Neurol Neurosurg Psychiatry 1986;49(4):375-80
   PubMedGoogle Scholar
• Tinuper P, Cerullo A, Cirignotta F, Nocturnal paroxysmal dystonia with short-lasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures. Epilepsia 1990;31(5):549-56
   PubMedGoogle Scholar
• Tinuper P, Provini F, Bisulli F, Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. Sleep Med Rev 2007;11(4):255-67
   PubMedGoogle Scholar
• Steinlein OK. Nicotinic acetylcholine receptors and epilepsy. Curr Drug Targets CNS Neurol Disord 2002;1(4):443-8
   PubMedGoogle Scholar
• Steinlein OK. Genetic disorders caused by mutated acetylcholine receptors. Life Sci 2007;80(24-25):2186-90
   PubMedGoogle Scholar
• Kikuchi T, Nomura M, Tomita H, Paroxysmal kinesigenic choreoathetosis (PKC): confirmation of linkage to 16p11-q21, but unsuccessful detection of mutations among 157 genes at the PKC-critical region in seven PKC families. J Hum Genet 2007;52(4):334-41
   PubMedGoogle Scholar
• Guerrini R, Bonanni P, Nardocci N, Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol 1999;45(3):344-52
   PubMedGoogle Scholar
• Kato N, Sadamatsu M, Kikuchi T, Paroxysmal kinesigenic choreoathetosis: from first discovery in 1892 to genetic linkage with benign familial infantile convulsions. Epilepsy Res 2006;70(Suppl 1):S174-84
   PubMedGoogle Scholar
• Tomita H, Nagamitsu S, Wakui K, Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet 1999;65(6):1688-97
   PubMedGoogle Scholar
• Valente EM, Spacey SD, Wali GM, A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain 2000;123(Pt 10):2040-5
   PubMedGoogle Scholar
• Weber YG, Jacob M, Weber G, A BFIS-like syndrome with late onset and febrile seizures: suggestive linkage to chromosome 16p11.2-16q12.1. Epilepsia 2008;49(11):1959-64
   PubMedGoogle Scholar
• Bhatia KP. The paroxysmal dyskinesias. J Neurol 1999;246(3):149-55
   PubMedGoogle Scholar
• Bhatia KP. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol 2001;21(1):69-74
   PubMedGoogle Scholar
• Bruno MK, Hallett M, Gwinn-Hardy K, Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 2004;63(12):2280-7
   PubMedGoogle Scholar
• Zhou J, Li G, Chen C, Familial pure paroxysmal kinesigenic dyskinesia in Han population from the Chinese mainland: a new subtype? Epilepsy Res 2008;80(2-3):171-9
   PubMedGoogle Scholar
• Djarmati A, Svetel M, Momcilovic D, Significance of recurrent mutations in the myofibrillogenesis regulator 1 gene. Arch Neurol 2005;62(10):1641
   PubMedGoogle Scholar
• Lee HY, Xu Y, Huang Y, The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004;13(24):3161-70
   PubMedGoogle Scholar
• Rainier S, Thomas D, Tokarz D, Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol 2004;61(7):1025-9
   PubMedGoogle Scholar
• Stefanova E, Djarmati A, Momcilovic D, Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with Myofibrillogenesis regulator 1 gene mutation. Mov Disord 2006;21(11):2010-15
   PubMedGoogle Scholar
• Spacey SD, Adams PJ, Lam PC, Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology 2006;66(10):1588-90
   PubMedGoogle Scholar
• Bruno MK, Lee HY, Auburger GW, Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007;68(21):1782-9
   PubMedGoogle Scholar
• Dressler D, Benecke R. Diagnosis and management of acute movement disorders. J Neurol 2005;252(11):1299-306
   PubMedGoogle Scholar
• Hinson VK, Haren WB. Psychogenic movement disorders. Lancet Neurol 2006;5(8):695-700
   PubMedGoogle Scholar
• Kamm C, Mayer P, Sharma M, New family with paroxysmal exercise-induced dystonia and epilepsy. Mov Disord 2007;22(6):873-7
   PubMedGoogle Scholar
• Munchau A, Valente EM, Shahidi GA, A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study. J Neurol Neurosurg Psychiatry 2000;68(5):609-14
   PubMedGoogle Scholar
• Suls A, Dedeken P, Goffin K, Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008;131(Pt 7):1831-44
   PubMedGoogle Scholar
• Weber YG, Storch A Wuttke TV, GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008;118(6):2157-68
   PubMedGoogle Scholar
• Schneider SA, Paisan-Ruiz C, Garcia-Gorostiaga I, GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord 2009;24(11):1684-8
   PubMedGoogle Scholar
• De Vivo DC, Trifiletti RR, Jacobson RI, Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991;325(10):703-9
   PubMedGoogle Scholar
• Pons R, Collins A, Rotstein M, The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 2010;25(3):275-81
   PubMedGoogle Scholar
• Klein C, Vieregge P. Non-epileptic paroxysmal movement disorders. Nervenarzt 1998;69(8):647-59
   PubMedGoogle Scholar
• Zenzola A, De Mari M, De Blasi R, Paroxysmal dystonia with thalamic lesion in multiple sclerosis. Neurol Sci 2001;22(5):391-4
   PubMedGoogle Scholar
• Camac A, Greene P, Khandji A. Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct. Mov Disord 1990;5(3):235-8
   PubMedGoogle Scholar
• Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord 2002;17(4):726-34
   PubMedGoogle Scholar
• Mehta SH, Morgan JC, Sethi KD. Paroxysmal dyskinesias. Curr Treat Options Neurol 2009;11(3):170-8
   PubMedGoogle Scholar
• Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics 2007;119(3):535-43
   PubMedGoogle Scholar
• Hartman AL, Gasior M, Vining EP, The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007;36(5):281-92
   PubMedGoogle Scholar
• Nylen K, Likhodii S, Burnham WM. The ketogenic diet: proposed mechanisms of action. Neurotherapeutics 2009;6(2):402-5
   PubMed Web of Science ®Google Scholar
• Unterberger I, Dobesberger J, Walser G, Paroxysmale Dyskinesien. Zeitschrift fur Epileptologie 2007;20(3):143-50
   Google Scholar
• Tsai JD, Chou IC, Tsai FJ, Clinical manifestation and carbamazepine treatment of patients with paroxysmal kinesigenic choreoathetosis. Acta Paediatr Taiwan 2005;46(3):138-42
   PubMedGoogle Scholar
• Uberall MA, Wenzel D. Effectiveness of lamotrigine in children with paroxysmal kinesigenic choreoathetosis. Dev Med Child Neurol 2000;42(10):699-700
   PubMedGoogle Scholar
• Huang YG, Chen YC, Du F, Topiramate therapy for paroxysmal kinesigenic choreoathetosis. Mov Disord 2005;20(1):75-7
   PubMedGoogle Scholar
• Tsao CY. Effective treatment with oxcarbazepine in paroxysmal kinesigenic choreoathetosis. J Child Neurol 2004;19(4):300-1
   PubMedGoogle Scholar
• Chatterjee A, Louis ED, Frucht S. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis. Mov Disord 2002;17(3):614-15
   PubMedGoogle Scholar
• Szczaluba K, Jurek M, Szczepanik E, A family with paroxysmal nonkinesigenic dyskinesia: genetic and treatment issues. Pediatr Neurol 2009;41(2):135-8
   PubMedGoogle Scholar
• McGrath TM, Dure LS. Paroxysmal dyskinesias in children. Curr Treat Options Neurol 2003;5(4):275-8
   PubMedGoogle Scholar
• Hall DA, Parsons J, Benke T. Paroxysmal nonkinesigenic dystonia and celiac disease. Mov Disord 2007;22(5):708-10
   PubMedGoogle Scholar
• Burk K, Farecki ML, Lamprecht G, Neurological symptoms in patients with biopsy proven celiac disease. Mov Disord 2009;24(16):2358-62
   PubMedGoogle Scholar
• Alemdar M, Iseri P, Selekler M, Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia. Clin Neuropharmacol 2007;30(4):241-4
   PubMedGoogle Scholar
• Vles GF, Hendriksen JG, Visschers A, Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy. Dev Med Child Neurol 2009;51(6):487-90
   PubMedGoogle Scholar
• Loher TJ, Krauss JK, Burgunder JM, Chronic thalamic stimulation for treatment of dystonic paroxysmal nonkinesigenic dyskinesia. Neurology 2001;56(2):268-70
   PubMedGoogle Scholar
• Yamada K, Goto S, Soyama N, Complete suppression of paroxysmal nonkinesigenic dyskinesia by globus pallidus internus pallidal stimulation. Mov Disord 2006;21(4):576-9
   PubMedGoogle Scholar
• Bhatia KP, Marsden CD, Thomas DG, Posteroventral pallidotomy can ameliorate attacks of paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry 1998;65(4):604-5
   PubMedGoogle Scholar
• Kinsbourne M. Hiatus hernia with contortions of the neck. Lancet 1964;13:1058-61
   Google Scholar
• Shahnawaz M, van der Westhuizen LR, Gledhill RF. Episodic cervical dystonia associated with gastro-oesophageal reflux. A case of adult-onset Sandifer syndrome. Clin Neurol Neurosurg 2001;103(4):212-15
   PubMedGoogle Scholar
• Somjit S, Lee Y, Berkovic SF, Sandifer syndrome misdiagnosed as refractory partial seizures in an adult. Epileptic Disord 2004;6(1):49-50
   PubMedGoogle Scholar
• Baumgartner RW, Baumgartner I. Vasomotor reactivity is exhausted in transient ischaemic attacks with limb shaking. J Neurol Neurosurg Psychiatry 1998;65(4):561-4
   PubMedGoogle Scholar
• Persoon S, Kappelle J, Klijn CJ. Limb-shaking transient ischaemic attacks in patients with internal carotid artery occlusion: a case-control study. Brain 2010;133(Pt3):915-22
   PubMedGoogle Scholar
• Harden CL, Meador KJ, Pennell PB, Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):133-41
   PubMedGoogle Scholar
• Meador KJ, Baker GA, Browning N, Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360(16):597-605
   Google Scholar
• Harden CL, Pennell PB, Koppel BS, Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):142-9
   PubMedGoogle Scholar
• Ito S, Oguni H, Ito Y, Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome. Brain Dev 2008;30(3):226-8
   PubMedGoogle Scholar